JPRN-UMIN000004489已完成未知
comparison of Therapy with Olmesartan medoxomil monotherapy or azelnidipine and olmesartan medoxomil combination in hypertensive patients with chronic KIdney disease - TOKI Study
iigata University0 个研究点目标入组 80 人开始时间: 2010年11月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Secondary hypertension or malignant hypertension (within hypertension in level 3) 2) Severe heart failure (NYHA Class is equal or more than III) 3) Atrial fibrillation or flutter with severe arrhythmia 4) Severe renal failure or liver failure (patient on dialysis, AST or ALT is more than 5 times higher upper limits) 5) Not appropriate for change to the test drugs from current therapy for coronary disease (i.e. CCB, diuretics, etc.) 6) Patient with severe adverse effects by RAS inhibitor, CCB and diuretic 7) Patient has merged the disease seems to be bad, such as malignant tumor prognosis. 8) Type 1 diabetes and type 2 diabetes required hospitalization due to high hemoglobin A1c (equal and more than 9.0%), extremely high blood glucose, or diabetic ketoacidosis. 9) Patients already used other CCB or a diuretic. 10) Pregnant, possible to be pregnant, or willing to be pregnant 11) Patients who are inadequate by determination of physician in charge
研究者
相似试验
进行中（未招募）
不适用
Treat-to-target study of olmesartan medoxomil and an add-on treatment algorithm consisting of hydrochlorothiazide and amlodipine besylate in patients with mild to moderate hypertension - Treat to target-OLMETREATMild to moderate hypertensionEUCTR2005-004659-36-PTDaiichi Sankyo Europe GmbH720
进行中（未招募）
不适用
Treat-to-target study of olmesartan medoxomil and an add-on treatment algorithm consiting of hydrochlorothiazide and amlodipine besylate in patients with mild to moderate hypertension - Treat to target -OLMETREATMild to moderate hypertensionEUCTR2005-004659-36-ATSankyo Pharma GmbH720
进行中（未招募）
1 期
Treat-to-target study of olmesartan medoxomil and an add-on treatment algorithm consisting of hydrochlorothiazide and amlodipine besylate in patients with mild to moderate hypertension - Treat to target-OLMETREATEUCTR2005-004659-36-GBSankyo Pharma GmbH720
进行中（未招募）
不适用
Treat-to-target study of olmesartan medoxomil and an add-on treatment algorithm consisting of hydrochlorothiazide and amlodipine besylate in patients with mild to moderate hypertension - Treat to target - OLMETREATEUCTR2005-004659-36-BEDaiichi SankyoGmbH720
进行中（未招募）
不适用
Treat-to-target study of olmesartan medoxomil and an add-on treatment algorithm consisting of hydrochlorothiazide and amlodipine besylate in patients with mild to moderate hypertension - Treat to target - OLMETREATEUCTR2005-004659-36-DEDaiichi Sankyo Europe GmbH720